HomeHealth NewsImmunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX...

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News

November 9, 2021

- Advertisement -

J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.
ABSTRACT
PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood.
METHODS: We performed a prospective cohort…

Click here to view the original article.

Tags
Australia
Docwirenews.com

- Advertisment -

Golden Eagle prizemoney to overtake Melbourne Cup – Racenet

Police officer summonsed over alleged PFVO breaches

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News

Recently Viewed

Lady Rose Gilman leads the glamour in the Wimbledon Royal Box on Day Two of the Championships

Eurobodalla Animal Welfare League’s Pets of the Week: Meet Callie and Buster!

AMP’s Diana Mousina and more join Finance Marketing Summit lineup

Hire ute leaves incriminating trail of two men allegedly illegally dumping near Goulburn

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

Who is Oscar Piastri’s girlfriend? Meet Lily Zneimer, the engineering extraordinaire and low-profile Brit who might just be the future of F1

Bryce Cotton headlines ESPN’s week of live FIBA basketball

Following a principled stance against Hansonism

POPULAR CATEGORY

FOLLOW US

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US